RPG Life Sciences Limited (BOM:532983)
India · Delayed Price · Currency is INR 1,978.20
-28.60 (-1.43%)
At close: Feb 13, 2026
RPG Life Sciences Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | - | 287 | 197.2 | 248.2 | 569.4 | 403.6 |
Short-Term Investments | - | 1,100 | 160 | 315.5 | 128.6 | - |
Trading Asset Securities | - | 1,259 | 901.5 | 584.3 | - | - |
Cash & Short-Term Investments | 2,235 | 2,646 | 1,259 | 1,148 | 698 | 403.6 |
Cash Growth | 77.48% | 110.22% | 9.64% | 64.47% | 72.94% | 7374.07% |
Accounts Receivable | - | 867.6 | 491.3 | 374.3 | 329.9 | 574.2 |
Other Receivables | - | 36.6 | 18.1 | 14.4 | 42.6 | 44.3 |
Receivables | - | 904.2 | 509.4 | 388.9 | 372.7 | 618.5 |
Inventory | - | 929.8 | 1,010 | 950.5 | 829.9 | 583.3 |
Prepaid Expenses | - | 24.5 | 25.3 | 30.7 | - | - |
Other Current Assets | - | 148 | 177.5 | 122.4 | 168.5 | 153.1 |
Total Current Assets | - | 4,653 | 2,981 | 2,641 | 2,069 | 1,759 |
Property, Plant & Equipment | - | 1,651 | 1,818 | 1,163 | 1,001 | 879.4 |
Long-Term Investments | - | 10.1 | 10.1 | - | - | - |
Other Intangible Assets | - | 227.6 | 280.3 | 334 | 346.8 | 371.3 |
Long-Term Deferred Tax Assets | - | 10 | 5.8 | - | - | 0.6 |
Other Long-Term Assets | - | 24.9 | 31.6 | 54.2 | 27.7 | 22.3 |
Total Assets | - | 6,578 | 5,129 | 4,194 | 3,446 | 3,034 |
Accounts Payable | - | 793.9 | 710.2 | 646.9 | 455 | 474.4 |
Accrued Expenses | - | 147.8 | 306.2 | 217.8 | 145.5 | 131.8 |
Short-Term Debt | - | - | - | - | 2.1 | 5.2 |
Current Portion of Long-Term Debt | - | - | - | 0.1 | 0.7 | 1.1 |
Current Portion of Leases | - | - | - | - | 3.6 | 6.5 |
Current Income Taxes Payable | - | - | 27.2 | - | 3.8 | - |
Other Current Liabilities | - | 256.6 | 266 | 163 | 190.4 | 177.9 |
Total Current Liabilities | - | 1,198 | 1,310 | 1,028 | 801.1 | 796.9 |
Long-Term Debt | - | - | - | - | 0.1 | 0.9 |
Long-Term Leases | - | - | - | - | 2.9 | 6.5 |
Long-Term Deferred Tax Liabilities | - | - | - | 19.7 | 22.6 | - |
Other Long-Term Liabilities | - | 74.5 | 70.6 | 70 | 61.7 | 65.1 |
Total Liabilities | - | 1,273 | 1,380 | 1,118 | 888.4 | 869.4 |
Common Stock | - | 132.3 | 132.3 | 132.3 | 132.3 | 132.3 |
Additional Paid-In Capital | - | 344.6 | 344.6 | 344.6 | 344.6 | 344.6 |
Retained Earnings | - | 4,828 | 3,271 | 2,599 | 2,080 | 1,687 |
Comprehensive Income & Other | - | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
Shareholders' Equity | 5,540 | 5,305 | 3,749 | 3,076 | 2,558 | 2,165 |
Total Liabilities & Equity | - | 6,578 | 5,129 | 4,194 | 3,446 | 3,034 |
Total Debt | - | - | - | 0.1 | 9.4 | 20.2 |
Net Cash (Debt) | 2,235 | 2,646 | 1,259 | 1,148 | 688.6 | 383.4 |
Net Cash Growth | 77.48% | 110.22% | 9.65% | 66.70% | 79.60% | - |
Net Cash Per Share | 135.15 | 159.99 | 76.10 | 69.41 | 41.63 | 23.18 |
Filing Date Shares Outstanding | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 |
Total Common Shares Outstanding | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 | 16.54 |
Working Capital | - | 3,454 | 1,671 | 1,613 | 1,268 | 961.6 |
Book Value Per Share | 334.93 | 320.77 | 226.65 | 185.98 | 154.65 | 130.87 |
Tangible Book Value | 5,340 | 5,078 | 3,468 | 2,742 | 2,211 | 1,793 |
Tangible Book Value Per Share | 322.86 | 307.01 | 209.70 | 165.79 | 133.68 | 108.42 |
Land | - | 109.4 | 202 | 202 | 23.4 | 19.5 |
Buildings | - | 770.2 | 477 | 464.1 | 329.7 | 323.6 |
Machinery | - | 1,203 | 865.9 | 865.4 | 662.3 | 614.3 |
Construction In Progress | - | 39.5 | 847.8 | 150.3 | 254.5 | 94.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.